MIR99AHG and breast carcinoma: LncRNA cyclin D1-interacting long noncoding RNA 1 (DILA1), which is overexpressed in tamoxifen-resistant breast cancer cells, can reduce the ubiquitination of cyclin D1, thus resulting in breast cancer cells being less sensitive to tamoxifen treatment [54].